Adrenal gland – GPM6A negative adrenocortical adenoma.
Adrenal gland – GPM6A negative pheochromocytoma.
Anal canal – GPM6A negative squamous cell carcinoma.
Breast – GPM6A negative invasive breast cancer of no special type (NST).
Breast – GPM6A negative invasive lobular breast cancer.
Cerebrum – Glioblastoma multiforme exhibiting a diffuse GPM6A staining.
Cerebrum – Glioblastoma multiforme with strong GPM6A staining of tumor cells.
Colon – GPM6A negative colorectal adenocarcinoma.
Esophagus – GPM6A negative adenocarcinoma.
Esophagus – GPM6A negative squamous cell carcinoma.
Ileum – Neuroendocrine tumor with strong membranous GPM6A staining of most tumor cells.
Kidney – GPM6A negative clear cell carcinoma.
Kidney – GPM6A negative papillary renal cell carcinoma.
Liver – GPM6A negative cholangiocellular carcinoma.
Liver – GPM6A negative hepatocellular carcinoma.
Lymph node – B-CLL with weak to strong membranous GPM6A positivity of at least a large subset tumor cells.
Lymph node – Diffuse large B-cell lymphoma with moderate to strong GPM6A staining of most tumor cells.
Oral cavity – GPM6A negative squamous cell carcinoma.
Ovary – GPM6A negative clear cell carcinoma.
Ovary – GPM6A negative endometroid carcinoma.
Ovary – GPM6A negative serous high-grade carcinoma.
Pancreas – GPM6A negative ductal adenocarcinoma.
Pancreas – GPM6A negative neuroendocrine tumor.
Penis – GPM6A negative squamous cell carcinoma.
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong membranous GPM6A staining of all tumor cells.
Prostate – GPM6A negative adenocarcinoma (Gleason 3+3=6).
Salivary gland – GPM6A negative Warthin tumor.
Skin – GPM6A negative malignant melanoma.
Soft tissue – GPM6A negative leiomyosarcoma.
Stomach – GPM6A negative gastric adenocarcinoma (diffuse type).
Stomach – GPM6A negative gastric adenocarcinoma.
Stomach – GPM6A negative gastrointestinal stromal tumor (GIST).
Testis – GPM6A negative seminoma.
Urinary bladder – GPM6A negative muscle-invasive urothelial carcinoma.
Urinary bladder – Muscle-invasive urothelial carcinoma with membranous GPM6A staining of most tumor cells (variable staining intensity).